Camedon

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 558066

CAS#: 144696-36-6

Description: Camedon is an interferon inducer.


Chemical Structure

No image available
Camedon
CAS# 144696-36-6

Theoretical Analysis

MedKoo Cat#: 558066
Name: Camedon
CAS#: 144696-36-6
Chemical Formula:
Exact Mass:
Molecular Weight:
Elemental Analysis:

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym:

IUPAC/Chemical Name: N/A

InChi Key: FQMLTEAEJZVTAJ-UHFFFAOYSA-M

InChi Code: 1S/C15H11NO3.Na/c17-14(18)9-16-12-7-3-1-5-10(12)15(19)11-6-2-4-8-13(11)16;/h1-8H,9H2,(H,17,18);/q;+1/p-1

SMILES Code: [Na+].c1cccc2n(c3ccccc3c(c12)=O)CC(=O)[O-]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Barinskiĭ IF, Davydova AA, Gribencha SV, Lazarenko AA. [Effectiveness of the interferon inducers ridostin and camedon in prevention and treatment of experimental alpha- and flavivirus infections]. Vopr Virusol. 1996 May-Jun;41(3):133-5. Russian. PubMed PMID: 8928508.

2: Nosik NN, Nosik DN, Kuznetsova NV. [The inhibiting action of interferon inducers on the multiplication of the human immunodeficiency virus]. Vopr Virusol. 1992 Mar-Apr;37(2):92-4. Russian. PubMed PMID: 1441434.

3: Glushkov NI, Guliaev AV, Pavelets KV, Musukaev KhM, Chërnykh DA, Ioganson DR. [Improvement in the diagnosis, therapy, and prevention of complications in patients with rectal cancer]. Vopr Onkol. 2012;58(4):498-501. Russian. PubMed PMID: 23607204.

4: Glushkov NI, Shabashova NV, Frolova EV, Uchevatkina AE, Kubachev KG, Novakovskiĭ VV, Popkov VV. [The efficacy of Neovir in the combined treatment of patients with operable tumors of the gastrointestinal tract]. Vestn Khir Im I I Grek. 1999;158(2):59-61. Russian. PubMed PMID: 10368895.

5: Maksimov SL, Iushchuk ND, Roslyĭ IM, Kravchenko AV, Danilova TV. [Neovir therapy in acute hepatitis C]. Zh Mikrobiol Epidemiol Immunobiol. 2003 Jan-Feb;(1):64-7. Russian. PubMed PMID: 12630357.

6: Cheknev SB, Mezentseva MV, Narovlyansky AN, Kobyakina NA, Ershov FI. Correlations between in vitro effects of preparations of interferon and its inducers on blood cells in patients with multiple sclerosis. Bull Exp Biol Med. 2001 Apr;131(4):382-4. PubMed PMID: 11550032.

7: Tsyrlina EV, Bakhidze EV, Volkova AT, Kriukova OG, Chepik OF, Maksimov SIa, Bershteĭn LM. [Effect of neoadjuvant therapy with neovir on the level of steroid hormone receptors in endometrial cancer tissue]. Vopr Onkol. 2001;47(2):214-7. Russian. PubMed PMID: 11383460.

8: HARADA K, KAMEDA M, SUZUKI M, MITSUHASHI S. DRUG RESISTANCE OF ENTERIC BACTERIA. 3. ACQUISITION OF TRANSFERABILITY OF NONTRANSMISSIBLE R(TC) FACTOR IN COOPERATION WITH F FACTOR AND FORMATION OF FR(TC). J Bacteriol. 1964 Nov;88:1257-65. PubMed PMID: 14234779; PubMed Central PMCID: PMC277402.

9: Surkov KG, Tsyrlina EV, Konstantinova MM, Bersteĭn LM. [Neovir, an interferon inductor, modifies expression of steroid hormone receptors in hormone-dependent tissues and restores sensitivity to tamoxifen in patients with inoperable breast cancer]. Vopr Onkol. 1996;42(6):28-32. Russian. PubMed PMID: 9123898.

10: KUROMARU G. The field investigation of tuberculosis made in Kameda-machi, Akita prefecture. Kekkaku. 1952 Jan;27(1):11-5; English extract, 48. PubMed PMID: 14918302.

11: Maksimov SL, Iushchuk ND, Roslyĭ IM, Kravchenko AV, Danilova TV. [Effect of neovir in the treatment of acute hepatitis C]. Zh Mikrobiol Epidemiol Immunobiol. 2001 May-Jun;(3):84-7. Russian. PubMed PMID: 11550570.

12: Zemskov AM, Korotkikh NG, Nektarevskaia IB, Suvorova IM. [Efficiency of immune correction in patients with chronic traumatic mandibular osteomyelitis]. Stomatologiia (Mosk). 2001;80(6):31-4. Russian. PubMed PMID: 11881458.

13: HARADA K, KAMEDA M, SUZUKI M, MITSUHASHI S. DRUG RESISTANCE OF ENTERIC BACTERIA. II. TRANSDUCTION OF TRANSMISSIBLE DRUG-RESISTANCE (R) FACTORS WITH PHAGE EPSILON. J Bacteriol. 1963 Dec;86:1332-8. PubMed PMID: 14086110; PubMed Central PMCID: PMC283650.

14: Mikhaĭlov IG, Maksimov SIa, Novik VI, Safronnikova NR, Vishnevskiĭ AS, Prianishnikov VA, Lyshev AA. [A comparative evaluation of treatment methods for a genital papillomavirus infection in women with different viral genotypes]. Vopr Onkol. 2000;46(3):340-3. Russian. PubMed PMID: 10976283.

15: Delektorskiĭ VV, Malinovskaia VV, Strizhakov AN, Iashkova GN, Kagramanova ZhA, Genkin DD, Parfenov VV, Galiautdinov DSh, Balandin AN, Lebedeva TV. [The interferon inducer neovir (kamedon) in the combined treatment of chronic inflammatory diseases of the adnexa uteri of chlamydial etiology (a clinical electron-microscopic study)]. Antibiot Khimioter. 1995 May;40(5):42-7. Russian. PubMed PMID: 8534181.